Taking antiretroviral therapy for HIV infection
- 33 Downloads
OBJECTIVE: To describe how people with HIV understand and experience the problem of adhering to antiretroviral medication regimens.
DESIGN: We performed a qualitative study based on interviews with HIV-infected patients, including 46 clients of AIDS service organizations, who were sampled according to age, ethnicity, and injection drug use history, and a convenience sample of 15 patients. Interviews were conducted in English or Spanish and were audiotaped and transcribed.
PARTICIPANTS: Of 52 respondents who had prescriptions for antiretroviral therapy, 25 were randomly selected for indepth analysis. Of these, 5 reported having an AIDS diagnosis, 15 reported symptoms they attributed to HIV, and 5 reported having no symptoms of HIV disease.
MEASUREMENTS AND MAIN RESULTS: Investigators prepared structured abstracts of interviews to extract adherence-related data. One investigator compared the abstracts with the original transcripts to confirm the interpretations, and used the abstracts to organize and classify the findings. Most subjects (84%) reported recent nonadherent behavior, including ceasing treatment, medication “holidays,” sleeping through doses, forgetting doses, skipping doses due to side effects, and following highly asymmetric schedules. Initially, most reported that they were not significantly nonadherent, and many did not consider their behavior nonadherent. Only a minority clearly understood the possible consequences of missing doses. Most said they had not discussed their nonadherence with their physicians.
CONCLUSIONS: Many people rationalize their difficulty in adhering to HIV treatment by deciding that the standard of adherence they can readily achieve is appropriate. Physicians should inquire about adherence-related behavior in specific detail, and ensure that patients understand the consequences of not meeting an appropriate standard.
Key wordsantiretroviral therapy adherence HIV
Unable to display preview. Download preview PDF.
- 3.Feinberg MB, Carpenter C, Fauci AS, et al. Report of the NIH Panel to Define Principles of Therapy of HIV Infection and guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents. Ann Intern Med. 1998;128:1057–110.Google Scholar
- 4.Paterson D, Seindels S, Mohr J, et al. How much adherence is enough? A prospective study of adherence to protease inhibitor therapy using MEMS Caps. Presented at the 6th Conference on Retroviruses and Opportunistic Infections; Jan 31-Feb 4, 1999. Washington, DC.Google Scholar
- 5.Bangsberg DR, Hecht FM, Charlebois EC, et al. Spontaneous adherence (ADH) audits (SAA) predict viral suppression in the REACH Cohort, Presented at the 6th Conference on Retroviruses and Opportunistic Infections; Jan 31-Feb 4, 1999. Washington, DC.Google Scholar
- 6.Demasi R, Tolson J, Pham S, et al Self-reported adherence to HAART and correlation with HIV RNA: initial results with the Patient Medication Adherence Questionnaire. Presented at the 6th Conference on Retroviruses and Opportunistic Infections; Jan 31-Feb 4, 1999. Washington, DC.Google Scholar
- 15.Lerner BH, Gulick RM, Dubler NN. Rethinking nonadherence: historical perspectives on triple-drug therapy for HIV disease. Ann Intern Med. 1999;14:53.Google Scholar
- 19.Rand CS, Weeks K. Measuring adherence with medication regimens in clinical care and research. In: Shumaker SA, Schron EB, Ockene JK, McBee WL, eds. The Handbook of Health Behavior Change. 2nd ed. New York: Springer Publishing Company, Inc.; 1998: 114–32.Google Scholar
- 20.Miles MB, Huberman MA. Qualitative Data Analysis: A Sourcebook of New Methods. Newbury Park, Calif: Sage Publications; 1984: 15.Google Scholar
- 24.Massachusetts AIDS Surveillance Program. Metropolitan area statistical data. Massachusetts Department of Public Health. January 1998.Google Scholar
- 27.Bradburn NM. Response effects. In: Rossi D, Wright JD, Anderson AB, eds. Handbook of Survey Research. San Diego, Calif: Academic Press; 1983.Google Scholar
- 29.Laws MB. Choice or Chance: Treatment Decision Making by People with HIV in Massachusetts. Boston: Latino Health Institute; 1999.Google Scholar
- 30.Glaser B, Strauss AL. The Discovery of Grounded Theory: Strategies for Qualitative Research. Chicago: Aldine; 1967.Google Scholar
- 31.Massachusetts Department of Public Health. Massachusetts AIDS Surveillance Monthly Update. April 1999.Google Scholar
- 32.Mar-Tang M, Noonan C, Ballard C, et al. Early adherence pattern and virologic outcomes after initiation or change of antiretroviral therapy. J Gen Intern Med. 1999;14:53. Abstract.Google Scholar
- 36.Golin C, Kaplan A, Liu HH, et al. Patient factors associated with and self-reported reasons for nonadherence to antiretroviral therapy. J Gen Intern Med. 1999;14:32. Abstract.Google Scholar
- 37.Gifford AL, Bormann JE, Shively MJ, Wright BC, Richman DD, Bozzette SA. The influence of social, psychological and clinical factors on antiretroviral medication adherence and plasma HIV levels. J Gen Intern Med. 1994;14:32. Abstract.Google Scholar
- 38.Wenger N, Gifford A, Liu H, et al. Patient characteristics and attitudes associated with antiretroviral (AR) adherence. Presented at the 6th Conference on Retroviruses and Opportunistic Infections; Jan 31-Feb 4, 1999. Washington, DC.Google Scholar
- 40.Bandura A. Social Foundations of Thought and Action. Englewood Cliffs, NJ: Prentice-Hall; 1986.Google Scholar
- 42.Prochaska JO, DiClemente CC. Stage of change in the modification of problem behaviors. In: Hersn M, Eisler RM, Miller PM, eds. Progress in Behavior Modification. Newbury Park, Calif: Sage; 1992.Google Scholar